Summary
16 / 100 · Bulios Score
Valuation 0Growth 50Profitability 0Quality 6Debt 34Stability 10
What speaks for it
- The price moves less than the market (beta 0.35).
What to watch
- The company made a loss over the last 12 months.
- It passes only 1 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
202120222023202420252026
Diluted EPS (EUR)
202120222023202420252026
- Analyst estimate
Revenue fell by 7.8% a year over 5 years. Over the last 3 years it grew by 6.1% a year.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Cash and short-term investments 4.59M €
Debt 18.5M €
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 3
- Sell 0
Today's price within the analysts' price targets
Today's price $9.8 Average target $12
$9.8 $12
The average target of $12 is 22% above today's price. 0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Services Member 97%
- Other Member 3.3%
By region
- GERMANY 50%
- BELGIUM 14%
- AUSTRIA 10%
- NETHERLANDS 10%
- Americas 7.9%
- Other 7.1%
Services Member brings in 97% of revenue.
Segments in detail